Neumora Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMRA and other ETFs, options, and stocks.

About NMRA

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience.

CEO

Paul L. Berns

CEOPaul L. Berns

Employees

110

Employees110

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2019

Founded2019

Employees

110

Employees110

NMRA Key Statistics

Market cap

113.48M

Market cap113.48M

Price-Earnings ratio

-0.44

Price-Earnings ratio-0.44

Dividend yield

—

Dividend yield—

Average volume

925.02K

Average volume925.02K

High today

$0.7174

High today$0.7174

Low today

$0.6549

Low today$0.6549

Open price

$0.6799

Open price$0.6799

Volume

1.20M

Volume1.20M

52 Week high

$17.19

52 Week high$17.19

52 Week low

$0.611

52 Week low$0.611

Analyst ratings

56%

of 9 ratings

Buy

33.3%

Hold

55.6%

Sell

11.1%

People also own

Based on the portfolios of people who own NMRA. This list is generated using Robinhood data, and it’s not a recommendation.

Faraday Future Intelligen…

Lucid Group